Management of pediatric renal tumor: Past and future trials of the Japan Wilms Tumor Study Group

Takaharu Oue, Masahiro Fukuzawa, Tsugumichi Koshinaga, Hajime Okita, Miwako Nozaki, Motoki Chin, Yasuhiko Kaneko, Yukichi Tanaka, Masayuki Haruta, Kunihiko Tsuchiya, Shigeko Kuwajima, Tetsuya Takimoto

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The Japan Wilms Tumor Study group (JWiTS) was founded in 1996 to improve outcomes for children with renal tumor in Japan, and a nationwide multicenter cooperative study was initiated thereafter. JWiTS-1 (1996-2005) was analyzed, and JWiTS-2 (2005-2014) is now under analysis; the following problems have been identified and used to decide future study protocol: (i) there has been a decline in survival rate for patients with rhabdoid tumor of the kidney (RTK) and new treatment strategies are required; (ii) the survival rate for bilateral Wilms tumors (BWT) has improved, but results for renal preservation are unsatisfactory; (iii) the prognosis of stage IV favorable nephroblastoma is very good, suggesting that the current protocols provide overtreatment, particularly for patients with lung metastasis; and (iv) no effective biological risk factors exist for predicting the outcome of Wilms tumor, and a study of the genetic changes of these tumors is necessary to determine biological markers for use in risk classification. To solve these issues, the development of a new risk classification of pediatric renal tumors is required. In addition, different study protocols should be developed according to the risk-based classification of the patients. Further, a new study protocol for BWT began in 2015, and new study protocols are being prepared for RTK, and for Wilms tumor with lung metastasis. In addition, an analysis of biological markers with regard to risk classification is to be performed. Furthermore, to create new protocols for patients with rare renal tumors, international collaboration with Children's Oncology Group and International Society of Pediatric Oncology is necessary.

Original languageEnglish
Pages (from-to)828-831
Number of pages4
JournalPediatrics International
Volume57
Issue number5
DOIs
Publication statusPublished - 2015 Oct 1
Externally publishedYes

Fingerprint

Wilms Tumor
Japan
Pediatrics
Kidney
Neoplasms
Rhabdoid Tumor
Survival Rate
Biomarkers
Neoplasm Metastasis
Lung
Biological Factors
Multicenter Studies

Keywords

  • prognostic factor
  • rhabdoid tumor of the kidney
  • risk classification
  • treatment
  • Wilms tumor

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Management of pediatric renal tumor : Past and future trials of the Japan Wilms Tumor Study Group. / Oue, Takaharu; Fukuzawa, Masahiro; Koshinaga, Tsugumichi; Okita, Hajime; Nozaki, Miwako; Chin, Motoki; Kaneko, Yasuhiko; Tanaka, Yukichi; Haruta, Masayuki; Tsuchiya, Kunihiko; Kuwajima, Shigeko; Takimoto, Tetsuya.

In: Pediatrics International, Vol. 57, No. 5, 01.10.2015, p. 828-831.

Research output: Contribution to journalArticle

Oue, T, Fukuzawa, M, Koshinaga, T, Okita, H, Nozaki, M, Chin, M, Kaneko, Y, Tanaka, Y, Haruta, M, Tsuchiya, K, Kuwajima, S & Takimoto, T 2015, 'Management of pediatric renal tumor: Past and future trials of the Japan Wilms Tumor Study Group', Pediatrics International, vol. 57, no. 5, pp. 828-831. https://doi.org/10.1111/ped.12787
Oue, Takaharu ; Fukuzawa, Masahiro ; Koshinaga, Tsugumichi ; Okita, Hajime ; Nozaki, Miwako ; Chin, Motoki ; Kaneko, Yasuhiko ; Tanaka, Yukichi ; Haruta, Masayuki ; Tsuchiya, Kunihiko ; Kuwajima, Shigeko ; Takimoto, Tetsuya. / Management of pediatric renal tumor : Past and future trials of the Japan Wilms Tumor Study Group. In: Pediatrics International. 2015 ; Vol. 57, No. 5. pp. 828-831.
@article{f03ec88473354300b19415f7a37efe71,
title = "Management of pediatric renal tumor: Past and future trials of the Japan Wilms Tumor Study Group",
abstract = "The Japan Wilms Tumor Study group (JWiTS) was founded in 1996 to improve outcomes for children with renal tumor in Japan, and a nationwide multicenter cooperative study was initiated thereafter. JWiTS-1 (1996-2005) was analyzed, and JWiTS-2 (2005-2014) is now under analysis; the following problems have been identified and used to decide future study protocol: (i) there has been a decline in survival rate for patients with rhabdoid tumor of the kidney (RTK) and new treatment strategies are required; (ii) the survival rate for bilateral Wilms tumors (BWT) has improved, but results for renal preservation are unsatisfactory; (iii) the prognosis of stage IV favorable nephroblastoma is very good, suggesting that the current protocols provide overtreatment, particularly for patients with lung metastasis; and (iv) no effective biological risk factors exist for predicting the outcome of Wilms tumor, and a study of the genetic changes of these tumors is necessary to determine biological markers for use in risk classification. To solve these issues, the development of a new risk classification of pediatric renal tumors is required. In addition, different study protocols should be developed according to the risk-based classification of the patients. Further, a new study protocol for BWT began in 2015, and new study protocols are being prepared for RTK, and for Wilms tumor with lung metastasis. In addition, an analysis of biological markers with regard to risk classification is to be performed. Furthermore, to create new protocols for patients with rare renal tumors, international collaboration with Children's Oncology Group and International Society of Pediatric Oncology is necessary.",
keywords = "prognostic factor, rhabdoid tumor of the kidney, risk classification, treatment, Wilms tumor",
author = "Takaharu Oue and Masahiro Fukuzawa and Tsugumichi Koshinaga and Hajime Okita and Miwako Nozaki and Motoki Chin and Yasuhiko Kaneko and Yukichi Tanaka and Masayuki Haruta and Kunihiko Tsuchiya and Shigeko Kuwajima and Tetsuya Takimoto",
year = "2015",
month = "10",
day = "1",
doi = "10.1111/ped.12787",
language = "English",
volume = "57",
pages = "828--831",
journal = "Pediatrics International",
issn = "1328-8067",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Management of pediatric renal tumor

T2 - Past and future trials of the Japan Wilms Tumor Study Group

AU - Oue, Takaharu

AU - Fukuzawa, Masahiro

AU - Koshinaga, Tsugumichi

AU - Okita, Hajime

AU - Nozaki, Miwako

AU - Chin, Motoki

AU - Kaneko, Yasuhiko

AU - Tanaka, Yukichi

AU - Haruta, Masayuki

AU - Tsuchiya, Kunihiko

AU - Kuwajima, Shigeko

AU - Takimoto, Tetsuya

PY - 2015/10/1

Y1 - 2015/10/1

N2 - The Japan Wilms Tumor Study group (JWiTS) was founded in 1996 to improve outcomes for children with renal tumor in Japan, and a nationwide multicenter cooperative study was initiated thereafter. JWiTS-1 (1996-2005) was analyzed, and JWiTS-2 (2005-2014) is now under analysis; the following problems have been identified and used to decide future study protocol: (i) there has been a decline in survival rate for patients with rhabdoid tumor of the kidney (RTK) and new treatment strategies are required; (ii) the survival rate for bilateral Wilms tumors (BWT) has improved, but results for renal preservation are unsatisfactory; (iii) the prognosis of stage IV favorable nephroblastoma is very good, suggesting that the current protocols provide overtreatment, particularly for patients with lung metastasis; and (iv) no effective biological risk factors exist for predicting the outcome of Wilms tumor, and a study of the genetic changes of these tumors is necessary to determine biological markers for use in risk classification. To solve these issues, the development of a new risk classification of pediatric renal tumors is required. In addition, different study protocols should be developed according to the risk-based classification of the patients. Further, a new study protocol for BWT began in 2015, and new study protocols are being prepared for RTK, and for Wilms tumor with lung metastasis. In addition, an analysis of biological markers with regard to risk classification is to be performed. Furthermore, to create new protocols for patients with rare renal tumors, international collaboration with Children's Oncology Group and International Society of Pediatric Oncology is necessary.

AB - The Japan Wilms Tumor Study group (JWiTS) was founded in 1996 to improve outcomes for children with renal tumor in Japan, and a nationwide multicenter cooperative study was initiated thereafter. JWiTS-1 (1996-2005) was analyzed, and JWiTS-2 (2005-2014) is now under analysis; the following problems have been identified and used to decide future study protocol: (i) there has been a decline in survival rate for patients with rhabdoid tumor of the kidney (RTK) and new treatment strategies are required; (ii) the survival rate for bilateral Wilms tumors (BWT) has improved, but results for renal preservation are unsatisfactory; (iii) the prognosis of stage IV favorable nephroblastoma is very good, suggesting that the current protocols provide overtreatment, particularly for patients with lung metastasis; and (iv) no effective biological risk factors exist for predicting the outcome of Wilms tumor, and a study of the genetic changes of these tumors is necessary to determine biological markers for use in risk classification. To solve these issues, the development of a new risk classification of pediatric renal tumors is required. In addition, different study protocols should be developed according to the risk-based classification of the patients. Further, a new study protocol for BWT began in 2015, and new study protocols are being prepared for RTK, and for Wilms tumor with lung metastasis. In addition, an analysis of biological markers with regard to risk classification is to be performed. Furthermore, to create new protocols for patients with rare renal tumors, international collaboration with Children's Oncology Group and International Society of Pediatric Oncology is necessary.

KW - prognostic factor

KW - rhabdoid tumor of the kidney

KW - risk classification

KW - treatment

KW - Wilms tumor

UR - http://www.scopus.com/inward/record.url?scp=84946020360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946020360&partnerID=8YFLogxK

U2 - 10.1111/ped.12787

DO - 10.1111/ped.12787

M3 - Article

C2 - 26267611

AN - SCOPUS:84946020360

VL - 57

SP - 828

EP - 831

JO - Pediatrics International

JF - Pediatrics International

SN - 1328-8067

IS - 5

ER -